期刊文献+

缬沙坦治疗糖尿病合并高血压的疗效观察 被引量:3

Effect Observation of Valsartan Treatment for Hypertensive Patients with Diabetes
下载PDF
导出
摘要 目的探讨缬沙坦治疗糖尿病合并高血压的疗效和安全性。方法选择76名糖尿病合并高血压患者,在维持糖尿病治疗的情况下,给予缬沙坦治疗,观察血压(收缩压SBP和舒张压DBP)、空腹血糖(FBG)、餐后2h血糖(2h—PBG)、糖化血红蛋白(HbAlc)、空腹胰岛素(INS)等的变化。结果76名糖尿病合并高血压患者经过缬沙坦的治疗,血压、空腹血糖、餐后2h血糖、糖化血红蛋白和空腹胰岛素均有明显的降低,治疗前后具有显著性差异。结论缬沙坦治疗糖尿病合并高血压疗效确切,副作用小,值得临床进一步推广应用。 Objective To investigate the effects of Valsartan in the hypertensive patients with diabetes. Methods 76 hypertensive patients with diabetes were treated by Valsartan for 14 weeks. Systolic and diastotic blood pressure (SBP, DBP), Blood Glucose, HbAlc, INS before and after treatment were examined. Results Compared to each other before and after treatment with Valsartan, SBP, DBP, FBG, 2h-PBG, HbAlc and INS were significantly decreased. Conclusion Valsartan can improve the hypertensive patients with diabetes effectively and is worthy of further application.
作者 黄慧 曾凡兰 喻蓉 徐莉琼 曾娟 HUANG Hui, ZENG Fan-lan, YU Rong, XU Li-qiong, ZENG Juan (Sichuan People's Hospital,Chengdu 610072, China)
出处 《医学信息》 2011年第9期2635-2636,共2页 Journal of Medical Information
关键词 糖尿病合并高血压 缬沙坦 疗效观察 Hypertension combined with Diabetes Valsartan Effect Observation
  • 相关文献

参考文献6

二级参考文献18

  • 1张承杰,田慧,潘长玉.糖尿病、高血压病及糖尿病伴高血压时心脏形态学变化的对照研究[J].北京医学,1994,16(3):131-134. 被引量:11
  • 2Sonkodi S,Mogyorosi A.Treatment of diabetic nephropathy with angiotensin Ⅱ blockers.Nephrol Dial Transplant,2003,18(suppl 5):v21-23.
  • 3Collister JP,Hendel MD.The role of Ang (1-7) in mediating the chronic hypotensive effects of losartan in normal rats.J Renin Angiotensin Aldosterone Syst,2003,4:176-179.
  • 4Taal MW,Brenner BM.Renoprotective benefits of RAS inhibition:from ACEI to angiotensin Ⅱ antagonists.Kidney Int,2000,57:1803-1817.
  • 5Raij L.Recommendations for the management of special populations:renal disease in diabetes.Am J Hypertens,2003,16(11Pt 2):46s-49s.
  • 6Parving HH,Andersen S,Jacobsen P,et al.Angiotensin receptor blockers in diabetic nephropathy:renal and cardiovascular end points.Semin Nephrol,2004,24:147 157.
  • 7Mangrum AJ,Bakris GL.Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic renal disease:safety issues.Semin Nephrol,2004,24:168-175.
  • 8Bedecs K,Elbaz N,Sutren M,et al.Angiotensin II type receptors mediate inhibition of mitogen activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase[].Biochemical Journal.1997
  • 9Liu Y,Leri A,Li B,et al.Angiotensin II stimulation in vitro induces hypertrophy of normal and postinfarcted ventricular myocytes[].Circulation Research.1998
  • 10Zini S,Fournie-Zaluski MC,Chauvel E,et al.Identification of metabolic pathways of brain angiotensin Ⅱ and Ⅲ using specific aminopeptidase inhibitors: predominant role of angiotensin Ⅲ in the control of vasopressin release[].Proceedings of the National Academy of Sciences of the United States of America.1996

共引文献74

同被引文献14

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部